Mark Burton

Dr. Mark Burton


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2019 in Proceedings of the Nutrition Society
Verified
Journal Article
Closed access
PDF file
MBMark Burton
Mark Burton
KLKaren A. Lillycrop
Karen A. Lillycrop
Non-communicable diseases (NCD) such as type-2 diabetes and CVD are now highly prevalent in both developed and developing countries. Evidence from both human and animal studies shows that early-life nutrition is an important determinant of NCD risk in later life. The mechanism by which the early-life environment influences future disease risk has been suggested to include the altered epigenetic regulation of gene expression. Epigenetic processes regulate the accessibility of genes to the cellular proteins that control gene transcription, determining where and when a gene is switched on and its level of activity. Epigenetic processes not only play a central role in regulating gene expression but also allow an organism to adapt to the environment. In this review, we will focus on how both maternal and paternal nutrition can alter the epigenome and the evidence that these changes are causally involved in determining future disease risk.

31 January 2024 in The FASEB Journal
Verified
Journal Article
Open access
MBMark Burton
Mark Burton
EAElie Antoun
Elie Antoun
EGEmma S. Garratt
Emma S. Garratt
LWLeo David Westbury
Leo David Westbury
EDElaine Dennison
Elaine Dennison
KLKaren A. Lillycrop
Karen A. Lillycrop
Small noncoding RNAs (sncRNAs) are implicated in age‐associated pathologies, including sarcopenia and insulin resistance (IR). As potential circulating biomarkers, most studies have focussed on microRNAs (miRNAs), one class of sncRNA. This study characterized the wider circulating sncRNA transcriptome of older individuals and associations with sarcopenia and IR. sncRNA expression including miRNAs, transfer RNAs (tRNAs), tRNA‐associated fragments (tRFs), and piwi‐interacting RNAs (piRNAs) was measured in serum from 21 healthy and 21 sarcopenic Hertfordshire Sarcopenia Study extension women matched for age (mean 78.9 years) and HOMA2‐IR. Associations with age, sarcopenia and HOMA2‐IR were examined and predicted gene targets and biological pathways characterized. Of the total sncRNA among healthy controls, piRNAs were most abundant (85.3%), followed by tRNAs (4.1%), miRNAs (2.7%), and tRFs (0.5%). Age was associated (FDR < 0.05) with 2 miRNAs, 58 tRNAs, and 14 tRFs, with chromatin organization, WNT signaling, and response to stress enriched among gene targets. Sarcopenia was nominally associated ( p < .05) with 12 tRNAs, 3 tRFs, and 6 piRNAs, with target genes linked to cell proliferation and differentiation such as Notch Receptor 1 ( NOTCH1 ), DISC1 scaffold protein ( DISC1 ), and GLI family zinc finger‐2 ( GLI2 ). HOMA2‐IR was nominally associated (p<0.05) with 6 miRNAs, 9 tRNAs, 1 tRF, and 19 piRNAs, linked with lysine degradation, circadian rhythm, and fatty acid biosynthesis pathways. These findings identify changes in circulating sncRNA expression in human serum associated with chronological age, sarcopenia, and IR. These may have clinical utility as circulating biomarkers of ageing and age‐associated pathologies and provide novel targets for therapeutic intervention.

15 September 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
MBMark Burton
Mark Burton
EAElie Antoun
Elie Antoun
RPReyna Peñailillo
Reyna Peñailillo
GBGraham Burdge
Graham Burdge
KLKaren A. Lillycrop
Karen A. Lillycrop
Folic acid (FA) intake has been associated with increased breast cancer risk in some studies. Although underlying mechanisms are unknown, epigenetic modifications that persistently alter transcription have been suggested. We tested the hypothesis that high FA (HFA) intake alters the adult mammary transcriptome in a manner consistent with increased potential for carcinogenesis, detectable beyond the period of intake. C57BL/6 mice were fed control FA (CFA) (1 mg/kg diet) or HFA (5 mg/kg diet) diets for 4 weeks, followed by AIN93M maintenance diet for 4 weeks. Plasma 5-methyltetrahydrofolate, p-aminobenzoylglutamate and unmetabolised FA concentrations were greater (1.62, 1.56, 5.80-fold, respectively) in HFA compared to CFA mice. RNA sequencing of the mammary transcriptome (~20 million reads) showed 222 transcripts (191 upregulated) differentially expressed between groups. Gene Set Enrichment showed upregulated genes significantly enriched in Epithelial Mesenchymal Transition, Myogenesis and Apical Junction and downregulated genes in E2F targets, MYC targets and G2M checkpoint. Cancer was the most altered Disease and Disorder pathway, with Metastasis, Mammary Tumour and Growth of Tumour the most upregulated pathways. ChIP-seq enrichment analysis showed that targets of histone methyltransferase EZH2 were enriched in HFA mice. This study demonstrates HFA intake during adulthood induces mammary transcriptome changes, consistent with greater tumorigenic potential.

17 February 2026 in Journal of Cachexia, Sarcopenia and Muscle
Verified
Journal Article
Open access
MBMark Burton
Mark Burton
EGEmma S. Garratt
Emma S. Garratt
HSHanan Y. Sharkh
Hanan Y. Sharkh
MHMatthew O. Hewitt
Matthew O. Hewitt
EAElie Antoun
Elie Antoun
KLKaren A. Lillycrop
Karen A. Lillycrop
Background: Ageing is associated with the loss of muscle mass and function, with consequences for metabolic health, frailty and independence in later life. The aim of this study was to investigate the transcriptional heterogeneity of human proliferating muscle satellite/stem cells (myoblasts) from older adults and how this heterogeneity may vary between healthy individuals and those with low muscle mass and function. Methods: Single‐cell transcriptomic analysis was carried out on proliferating myoblasts isolated from vastus lateralis biopsies from 132 participants (34 male, 98 female) aged 72–83 years from the Hertfordshire Sarcopenia Study extension. Uniform Manifold Approximation and Projection (UMAP) clustering was applied to identify clusters of myoblasts with distinct transcriptional profiles, Gene Ontology analysis was used to identify pathways enriched among the clusters, and pseudotime trajectory analysis was used to identify inferred cell lineages. Differential gene expression within cell clusters, together with the proportions of cells within each cluster and lineage, were assessed with respect to participant appendicular lean‐mass index (ALMi), grip strength, and gait speed. Results: Thirteen distinct cell clusters based on the transcriptional heterogeneity of the myoblasts were identified. Clusters 0–6 contained the majority (94.6%) of cells. Marker genes were enriched for cytoplasmic translation (Cluster 0, false discovery rate [FDR] = 7.21 × 10 −63 ), muscle development (Cluster 1, FDR = 2.25 × 10 −13 ), cell proliferation (Clusters 2, 4 and 6, all FDR ≤ 0.05), extracellular matrix organisation (Cluster 3, FDR = 1.92 × 10 −45 ) and RNA processing (Cluster 5, FDR = 1.89 × 10 −08 ). Individuals with the highest grip strength and ALMi had a greater proportion of Cluster 1 and Cluster 5 cells. Gene expression analysis (FDR ≤ 0.05) within the clusters identified 22 differentially expressed transcripts with respect to ALMi in Cluster 2 and 13 with respect to grip strength in Cluster 1. Inferred lineage analysis identified cells transitioning along five trajectories (L1–L5), including cells in L1, L3 and L4 progressing towards a stressed pre‐senescent/senescent (L1) or fibrogenic (L3 and L4) state, with cells in these lineages being more likely to originate from individuals with low ALMi (χ 2 p = 1.11 × 10 −146 ) and grip strength (χ 2 p = 1.31 × 10 −269 ). Conclusion: Our findings demonstrate considerable transcriptional heterogeneity in skeletal muscle myoblasts from older adults. This heterogeneity includes myoblasts from individuals with low muscle mass and strength progressing towards a fibrogenic or stressed state.

22 August 2016 in Reproduction Abstracts
Verified
Journal Article
Closed access
REReyna Penailillo Escarate
Reyna Penailillo Escarate
MBMark Burton
Mark Burton
GBGraham Burdge
Graham Burdge
JEJudith Eckert
Judith Eckert
TFTom Fleming
Tom Fleming
KLKaren Lillycrop
Karen Lillycrop
Introduction: Women with mutations in BRCA1 gene have an increased lifetime risk of ovarian cancer. Many studies but not all have shown that an adequate folate intake is protective against many cancers including ovarian, but recent studies have shown that high levels of folic acid (FA) supplementation can promote cancer risk. The aim of this study is to determine FA impact on the expression of cancer related genes in the ovary such as OCT4 a pluripotency factor, BRCA1 related to DNA repair and the chromatin modifying enzyme EZH2. Methods: Juvenile (4 wks old) or adult (10 wks old) female C57BL/6 mice were fed for 4 weeks with normal (1 mg/Kg), high (5 mg/Kg) or supramaximal (20 mg/kg) doses of FA and then kept on maintenance diet until 4 or 12 weeks after supplementation. Quantitative RT-PCR was performed to determine the mRNA levels. Results and Discussion: FA supplementation during the juvenile period led to an increase in Oct4, Brca1 and Ezh2 expression immediately after the treatment. However, those effects did not persist after the end of supplementation. In contrast, FA during adulthood led to an increase in Oct4, Brca1 and Ezh2, which persisted 4 weeks after the end of supplementation. These results show that FA affects the expression of cancer related genes in the ovary, but the effects are dependent on the dose and time of supplementation. Future work is needed to identify histological alterations on ovaries and if FA could modify the quality and/or quantity of ovarian follicles.